
NextStep Robotics is revolutionizing foot drop therapy with its groundbreaking wearable device, AMBLE. This device uniquely combines advanced robotics and proprietary algorithms to provide graded robotic assistance, empowering both patients and clinicians. AMBLE targets ankle impairments, particularly foot drop resulting from stroke, and aims to help patients regain mobility and independence. The company differentiates itself by creating devices from evidence, supported by peer-reviewed studies demonstrating AMBLE's effectiveness. Notably, 85% of patients reportedly discontinued assistive devices or AFOs after 6 weeks of AMBLE treatment. The team possesses over 20 years of combined experience in robotics and neurology. NextStep Robotics aims to provide an affordable rehab robotic with impactful outcomes, accessible to clinics of all sizes, enhancing gait retraining, increasing muscle strength, enabling personalized therapy plans, and offering objective progress tracking.

NextStep Robotics is revolutionizing foot drop therapy with its groundbreaking wearable device, AMBLE. This device uniquely combines advanced robotics and proprietary algorithms to provide graded robotic assistance, empowering both patients and clinicians. AMBLE targets ankle impairments, particularly foot drop resulting from stroke, and aims to help patients regain mobility and independence. The company differentiates itself by creating devices from evidence, supported by peer-reviewed studies demonstrating AMBLE's effectiveness. Notably, 85% of patients reportedly discontinued assistive devices or AFOs after 6 weeks of AMBLE treatment. The team possesses over 20 years of combined experience in robotics and neurology. NextStep Robotics aims to provide an affordable rehab robotic with impactful outcomes, accessible to clinics of all sizes, enhancing gait retraining, increasing muscle strength, enabling personalized therapy plans, and offering objective progress tracking.
Product: AMBLE wearable ankle exoskeleton for clinical gait/foot-drop rehabilitation
Headquarters: Baltimore, Maryland (University of Maryland BioPark)
Founded: 2017 (University of Maryland spinout)
Employees: Approximately 11–50 (employee_count reported as 16)
Funding (reported): Total disclosed funding $3,600,000; Seed round led by TEDCO
Clinical gait rehabilitation for ankle impairments, especially foot drop resulting from stroke and other neurological conditions.
2017
Medical robotics / Rehabilitation technology
Seed round reported with TEDCO as lead investor; additional investors reported include Abell Foundation, University System of Maryland Momentum Fund, and angel investor Jeff Quinn.
“Investors reported include TEDCO (lead), Abell Foundation, University System of Maryland Momentum Fund, and angel investor Jeff Quinn”